Mazen Hanna, M.D.
| Appointed: |
2006 |
| Gender: |
Male |
| Languages: |
Arabic
English
Spanish |
Cardiovascular Medicine
Transplantation Center
Critical Care Center
Biographical Sketch
Mazen Hanna, MD, is a Cardiologist with advanced training in heart failure and cardiac transplantation. He is the local Principal Investigator for two international multicenter trials that are currently enrolling patients with congestive heart failure. He also has experience with left ventricular assist devices. Other special interests include anemia in heart failure as well as hypertrophic cardiomyopathy.
Education & Fellowships
| Medical School: | The Ohio State University College of Medicine and Public Health, Columbus, OH |
|
| Internship: | Baylor College of Medicine, Internal Medicine, Houston, TX |
| Residency: | Baylor College of Medicine, Internal Medicine, Houston, TX |
| Residency: | Mount Sinai School of Medicine, Internal Medicine, New York, NY |
| Fellowship: | Cleveland Clinic, Heart Failure/Transplant, Cleveland, OH |
| Fellowship: | MetroHealth Medical Center, Cardiology, Cleveland, OH |
| Other Education: | (Undergraduate) Cornell University, Ithaca, NY |
Certifications
Internal Medicine
Cardiovascular Disease
Specialty Interests
Congestive heart failure, hypertrophic cardiomyopathy, heart transplantation and mechanical circulatory support devices.
Professional Memberships
- Heart Failure Society of America
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 10/24/2008 the review process regarding Dr. Hanna’s disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
